Veracyte, Inc. (VCYT)
Veracyte Market Cap : 3.541B for Aug. 25, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 3.333B |
| August 21, 2026 | 3.400B |
| August 20, 2026 | 3.358B |
| August 19, 2026 | 3.391B |
| August 18, 2026 | 3.269B |
| August 17, 2026 | 3.382B |
| August 14, 2026 | 3.315B |
| August 13, 2026 | 3.424B |
| August 12, 2026 | 3.591B |
| August 11, 2026 | 3.730B |
| August 10, 2026 | 3.718B |
| August 07, 2026 | 3.795B |
| August 06, 2026 | 3.709B |
| August 05, 2026 | 3.709B |
| August 04, 2026 | 3.730B |
| August 03, 2026 | 3.604B |
| July 31, 2026 | 3.722B |
| July 30, 2026 | 4.804B |
| July 29, 2026 | 4.477B |
| July 28, 2026 | 4.472B |
| July 27, 2026 | 4.437B |
| July 24, 2026 | 4.517B |
| July 23, 2026 | 4.618B |
| July 22, 2026 | 4.629B |
| July 21, 2026 | 4.750B |
| Date | Value |
|---|---|
| July 20, 2026 | 4.569B |
| July 17, 2026 | 4.718B |
| July 16, 2026 | 4.725B |
| July 15, 2026 | 4.748B |
| July 14, 2026 | 4.518B |
| July 13, 2026 | 4.586B |
| July 10, 2026 | 4.546B |
| July 09, 2026 | 4.732B |
| July 08, 2026 | 4.478B |
| July 07, 2026 | 4.481B |
| July 06, 2026 | 4.628B |
| July 02, 2026 | 4.555B |
| July 01, 2026 | 4.776B |
| June 30, 2026 | 4.686B |
| June 29, 2026 | 4.803B |
| June 26, 2026 | 4.827B |
| June 25, 2026 | 4.672B |
| June 24, 2026 | 4.529B |
| June 23, 2026 | 4.292B |
| June 22, 2026 | 4.244B |
| June 18, 2026 | 4.279B |
| June 17, 2026 | 4.093B |
| June 16, 2026 | 4.063B |
| June 15, 2026 | 3.922B |
| June 12, 2026 | 3.777B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Globus Medical, Inc. | 11.14B |
| Recursion Pharmaceuticals, Inc. | 1.899B |
| Anika Therapeutics, Inc. | 288.00M |
| Perspective Therapeutics, Inc. | 375.34M |
| Teleflex, Inc. | 5.933B |
Market Cap Related Metrics
| PE Ratio | 31.26 |
| PS Ratio | 6.360 |
| PEG Ratio | 0.0966 |
| Price to Book Value | 2.550 |
| Price to Free Cash Flow | 21.53 |
| Price | 44.06 |
| Earnings Yield | 3.20% |
| PEGY Ratio | 0.0966 |
| Operating PE Ratio | 36.93 |
| Normalized PE Ratio | 34.15 |